Senate Report Comes Down Hard on Avandia
Avandia is a diabetes drug that’s been on the market for over a decade. Its purpose is to help those with type 2 diabetes manage their condition in conjunction with a healthy diet and some form of an exercise program. Avandia is manufactured by GlaxoSmithKline and dominated the market after its release. Unfortunately, reports of serious Avandia side effects eventually began to surface, prompting inquiries to Avandia side effects lawyers around the country. Recently, another issue has been added to the overall Avandia controversy, and it involves a Senate report on the history of the drug and the issues it has faced. Overall, the conclusions of the report were not positive.
Reports of Avandia Side Effects Prompt Studies and Action by Government
After the initial reports of Avandia side effects began to surface, different entities began to get involved with the issue. One of the most dramatic developments in relation to this issue was a study’s conclusions that were published in the New England Journal of Medicine in 2007. This study concluded that those who had used Avandia faced a higher risk of developing serious Avandia side effects that included heart attacks and strokes.
In response to this report, the FDA issued an order that Avandia had to have a clear warning attached to its labels that described the potential dangers with Avandia side effects. The government also stated that it would analyze whether the benefits of keeping Avandia on the market outweighed the risks presented to those who used it. At this point, Avandia remains on the market.
Senate Report on Avandia Side Effects Criticizes GlaxoSmithKline and FDA
A Senate report was recently published concerning Avandia, and its conclusions were anything but positive. In the report, it was found that:
- Avandia could be responsible for approximately 83,000 heart attacks in patients who used it.
- GlaxoSmithKline made attempts to undermine the value of these reports of Avandia side effects.
- The FDA overlooked serious problems with Avandia when it decided to allow the drug to remain on the market.
While this report is not necessarily legally binding, it is a bipartisan work that will be very influential in the future dealings with both Avandia and GlaxoSmithKline. If you or someone you love has been harmed as a result of using Avandia, you need to take action. Contact the Avandia side effects lawyers at the Phillips National Injury Group today to schedule a free initial consultation.